Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC) on May 25, 2026 Posted by Adriana Carlson
A Powerhouse Alliance: Dreame Technology Names Cristiano Ronaldo as new Global Ambassador on May 25, 2026 Posted by Adriana Carlson
SK Minerals & Additives Reports Strong FY26 Profit Growth at INR 18.12 Crore on May 25, 2026 Posted by Neel Achary
A Digital Detox Like No Other at Four Seasons Resorts Maldives on May 25, 2026May 25, 2026 Posted by Neel Achary
Posted in News Vizzhy Inc Wins Nasscom AI Gamechangers Award 2023-24 in Healthcare & Pharma Startup Category on August 2, 2024August 2, 2024 Mansi Praharaj
